
Beemnet W. Dada
Examiner (ID: 2134, Phone: (571)272-3847 , Office: P/2435 )
| Most Active Art Unit | 2435 |
| Art Unit(s) | 2135, 2435 |
| Total Applications | 1486 |
| Issued Applications | 1172 |
| Pending Applications | 108 |
| Abandoned Applications | 217 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 15360767
[patent_doc_number] => 20200016148
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-16
[patent_title] => ANALOGS OF DEUTETRABENAZINE, THEIR PREPARATION AND USE
[patent_app_type] => utility
[patent_app_number] => 16/582362
[patent_app_country] => US
[patent_app_date] => 2019-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10304
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16582362
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/582362 | Analogs of deutetrabenazine, their preparation and use | Sep 24, 2019 | Issued |
Array
(
[id] => 15363335
[patent_doc_number] => 20200017432
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-16
[patent_title] => SUBSTITUTED AROMATIC COMPOUNDS FOR THE TREATMENT OF PULMONARY FIBROSIS, LIVER FIBROSIS,SKIN FIBROSIS AND CARDIAC FIBROSIS
[patent_app_type] => utility
[patent_app_number] => 16/580747
[patent_app_country] => US
[patent_app_date] => 2019-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21330
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 144
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16580747
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/580747 | Substituted aromatic compounds for the treatment of pulmonary fibrosis, liver fibrosis, skin fibrosis and cardiac fibrosis | Sep 23, 2019 | Issued |
Array
(
[id] => 15797021
[patent_doc_number] => 20200121653
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-23
[patent_title] => METHODS FOR TREATING IRRITABLE BOWEL SYNDROME (IBS)
[patent_app_type] => utility
[patent_app_number] => 16/575769
[patent_app_country] => US
[patent_app_date] => 2019-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19941
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16575769
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/575769 | METHODS FOR TREATING IRRITABLE BOWEL SYNDROME (IBS) | Sep 18, 2019 | Abandoned |
Array
(
[id] => 15405323
[patent_doc_number] => 20200022983
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-23
[patent_title] => TREATMENT OF RB-NEGATIVE TUMORS USING TOPOISOMERASE INHIBITORS IN COMBINATION WITH CYCLIN DEPENDENT KINASE 4/6 INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 16/572418
[patent_app_country] => US
[patent_app_date] => 2019-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37313
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16572418
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/572418 | Treatment of Rb-negative tumors using topoisomerase inhibitors in combination with cyclin dependent kinase 4/6 inhibitors | Sep 15, 2019 | Issued |
Array
(
[id] => 15615853
[patent_doc_number] => 20200078331
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-12
[patent_title] => Intranasal Compositions For Treatment of Neurological And Neurodegenerative Diseases And Disorders
[patent_app_type] => utility
[patent_app_number] => 16/569986
[patent_app_country] => US
[patent_app_date] => 2019-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19399
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16569986
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/569986 | Intranasal compositions for treatment of neurological and neurodegenerative diseases and disorders | Sep 12, 2019 | Issued |
Array
(
[id] => 15296057
[patent_doc_number] => 20190391164
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-26
[patent_title] => QUANTITATIVE METHODS AND KITS FOR PROVIDING REPRODUCIBLE IHC4 SCORES
[patent_app_type] => utility
[patent_app_number] => 16/563757
[patent_app_country] => US
[patent_app_date] => 2019-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10162
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16563757
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/563757 | QUANTITATIVE METHODS AND KITS FOR PROVIDING REPRODUCIBLE IHC4 SCORES | Sep 5, 2019 | Abandoned |
Array
(
[id] => 17330043
[patent_doc_number] => 11220496
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-01-11
[patent_title] => Compounds and method for treating autoimmune diseases
[patent_app_type] => utility
[patent_app_number] => 16/551431
[patent_app_country] => US
[patent_app_date] => 2019-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16007
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16551431
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/551431 | Compounds and method for treating autoimmune diseases | Aug 25, 2019 | Issued |
Array
(
[id] => 17154853
[patent_doc_number] => 20210315904
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-14
[patent_title] => BCL-2 INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 17/269004
[patent_app_country] => US
[patent_app_date] => 2019-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 97458
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 1132
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17269004
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/269004 | BCL-2 inhibitors | Aug 20, 2019 | Issued |
Array
(
[id] => 15206183
[patent_doc_number] => 20190365778
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-05
[patent_title] => TREPROSTINIL ADMINISTRATION BY INHALATION
[patent_app_type] => utility
[patent_app_number] => 16/536954
[patent_app_country] => US
[patent_app_date] => 2019-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8956
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16536954
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/536954 | TREPROSTINIL ADMINISTRATION BY INHALATION | Aug 8, 2019 | Abandoned |
Array
(
[id] => 15178079
[patent_doc_number] => 20190359631
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-28
[patent_title] => THERAPEUTIC AGENT FOR MOTOR DISORDERS
[patent_app_type] => utility
[patent_app_number] => 16/534167
[patent_app_country] => US
[patent_app_date] => 2019-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18333
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16534167
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/534167 | THERAPEUTIC AGENT FOR MOTOR DISORDERS | Aug 6, 2019 | Abandoned |
Array
(
[id] => 17140160
[patent_doc_number] => 20210308171
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-07
[patent_title] => METHODS FOR COMBINATORIAL SCREENING AND USE OF THERAPEUTIC TARGETS THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/266538
[patent_app_country] => US
[patent_app_date] => 2019-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 87780
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -92
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17266538
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/266538 | METHODS FOR COMBINATORIAL SCREENING AND USE OF THERAPEUTIC TARGETS THEREOF | Aug 6, 2019 | Pending |
Array
(
[id] => 17648443
[patent_doc_number] => 11351142
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-06-07
[patent_title] => Composition and method for treating neuronal ceroid lipofuscinosis
[patent_app_type] => utility
[patent_app_number] => 16/515836
[patent_app_country] => US
[patent_app_date] => 2019-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 72
[patent_no_of_words] => 12779
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16515836
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/515836 | Composition and method for treating neuronal ceroid lipofuscinosis | Jul 17, 2019 | Issued |
Array
(
[id] => 17065768
[patent_doc_number] => 20210267983
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-02
[patent_title] => COMBINATIONS OF PPAR AGONISTS AND P38 KINASE INHIBITORS FOR PREVENTING OR TREATING FIBROTIC DISEASES
[patent_app_type] => utility
[patent_app_number] => 17/259828
[patent_app_country] => US
[patent_app_date] => 2019-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16957
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17259828
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/259828 | COMBINATIONS OF PPAR AGONISTS AND P38 KINASE INHIBITORS FOR PREVENTING OR TREATING FIBROTIC DISEASES | Jul 4, 2019 | Abandoned |
Array
(
[id] => 19210676
[patent_doc_number] => 11999724
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-06-04
[patent_title] => Method for producing diarylpyridine derivatives
[patent_app_type] => utility
[patent_app_number] => 17/252469
[patent_app_country] => US
[patent_app_date] => 2019-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 8896
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17252469
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/252469 | Method for producing diarylpyridine derivatives | Jul 2, 2019 | Issued |
Array
(
[id] => 15975471
[patent_doc_number] => 10668036
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-06-02
[patent_title] => Deuterated analogs of D-serine and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/459916
[patent_app_country] => US
[patent_app_date] => 2019-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 16
[patent_no_of_words] => 16862
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16459916
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/459916 | Deuterated analogs of D-serine and uses thereof | Jul 1, 2019 | Issued |
Array
(
[id] => 15019213
[patent_doc_number] => 20190320611
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-24
[patent_title] => PRE-FRONTAL CORTEX PROCESSING DISORDER SPEECH GAIT AND LIMB IMPAIRMENTS TREATMENT
[patent_app_type] => utility
[patent_app_number] => 16/446678
[patent_app_country] => US
[patent_app_date] => 2019-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6467
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -43
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16446678
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/446678 | Pre-frontal cortex processing disorder speech gait and limb impairments treatment | Jun 19, 2019 | Issued |
Array
(
[id] => 17067199
[patent_doc_number] => 20210269414
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-02
[patent_title] => PROCESS FOR PREPARING TRICYCLIC COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 17/254729
[patent_app_country] => US
[patent_app_date] => 2019-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7559
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 309
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17254729
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/254729 | PROCESS FOR PREPARING TRICYCLIC COMPOUNDS | Jun 16, 2019 | Abandoned |
Array
(
[id] => 14893721
[patent_doc_number] => 20190290626
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-26
[patent_title] => METHOD OF TREATMENT WITH TRADIPITANT
[patent_app_type] => utility
[patent_app_number] => 16/430516
[patent_app_country] => US
[patent_app_date] => 2019-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3632
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16430516
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/430516 | METHOD OF TREATMENT WITH TRADIPITANT | Jun 3, 2019 | Abandoned |
Array
(
[id] => 15290597
[patent_doc_number] => 20190388434
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-26
[patent_title] => (17-ss)-3-Oxoandrost-4-En-17-Yl Undecanoate Compositions and Methods of Their Preparation and Use
[patent_app_type] => utility
[patent_app_number] => 16/427059
[patent_app_country] => US
[patent_app_date] => 2019-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33518
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16427059
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/427059 | (17-ss)-3-Oxoandrost-4-En-17-Yl Undecanoate Compositions and Methods of Their Preparation and Use | May 29, 2019 | Abandoned |
Array
(
[id] => 16784924
[patent_doc_number] => 10987323
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-04-27
[patent_title] => Combination comprising palmitoylethanolamide (PEA) and lycopene for use in the treatment of inflammatory diseases
[patent_app_type] => utility
[patent_app_number] => 16/424620
[patent_app_country] => US
[patent_app_date] => 2019-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5128
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 127
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16424620
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/424620 | Combination comprising palmitoylethanolamide (PEA) and lycopene for use in the treatment of inflammatory diseases | May 28, 2019 | Issued |